ExpansionJun 9, 2026, 08:31 AM
Microbot Medical's LIBERTY System Adopted by Michigan Health System
AI Summary
Microbot Medical announced that a major Michigan healthcare system has adopted its LIBERTY Endovascular Robotic System, marking its first presence in Michigan and the greater Midwest U.S. This follows a recent expansion into North Carolina, indicating growing interest and demand for advanced robotic solutions in peripheral endovascular procedures. The company highlights the U.S. market opportunity of approximately 2.5 million annual procedures and the LIBERTY system's unique FDA clearance and recent Israeli regulatory approval.
Key Highlights
- Michigan healthcare system adopted LIBERTY System, first in Michigan and the greater Midwest U.S.
- This follows the company's recent expansion into a North Carolina healthcare system.
- The U.S. market for peripheral endovascular procedures encompasses approximately 2.5 million procedures annually.
- LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- LIBERTY System recently received regulatory approval from the Israeli Ministry of Health's AMAR Division.
Price Impact
More from MBOT